AMAN PARHAR

Aman Parhar is a co-director of the Biotechnology Panel. He received a Five Years Integrated Masters in Biochemical Engineering and Biotechnology from the Indian Institute of Technology, Delhi. During his undergrad, he presented a research paper titled "Transport and Biochemical Reaction in Immobilized Cell Reactors: Correlation of Experiment with Theory" at an international Biotechnology seminar. After graduating from IIT, he worked at Deloitte Consulting as a generalist Consultant for four years. At Wharton, he is pursuing a dual degree program in MBA and an MS in Biotechnology. His long term professional goal is to help the development of Biotechnology in developing economies and emerging markets.

SVEN PFEIFFER

Sven Pfeiffer is a Director of the Biotech Panel and a first year MBA student at Wharton.  Sven received a MSc in Biophysics from Humboldt University of Berlin, Germany in 1997, and went on to earn a PhD in Developmental Biology from University College London in 2001.  Sven then joined Merlin Biosciences, a London-based pan-European biotech venture capital company.  As Investment Analyst Sven carried out Due Diligence on early to mid-stage product and platform technology companies.  Following his tenure at Merlin, Sven joined Apex Healthcare Consulting as Senior Business Analyst where he worked with mid-size pharmaceutical and biotech companies.

ANYA SCHIESS

Anya Schiess is co-chair of the biotechnology panel. She is a first-year. Since January 2003, Anya has worked for the William Jefferson Clinton Presidential Foundation HIV/AIDS Initiative. At the WJCPF, she developed HIV/AIDS care and treatment programs in the Eastern Caribbean States and supported negotiations for low-cost pharmaceuticals. Until June 2003, Anya was a consultant in the pharmaceutical and medical products practice and corporate finance practice for McKinsey & Company, a global strategy management consulting firm. Anya is actively involved in Junior Achievement.  Anya graduated cum laude from the Woodrow Wilson School of Public and International Affairs at Princeton University. Anya is proficient in Mandarin Chinese.

SIMOS SIMEONIDIS

Simos Simeonidis is co-Director of the Biotechnology Panel. He is a first year MBA student double-majoring in Health Care Management and Finance. He received his B.S. in Biology from Loyola University in Chicago, and his M.A., M.Phil. and Ph.D. in Cellular, Molecular and Biophysical Studies from Columbia University’s College of Physicians and Surgeons. At Columbia, he graduated first in his class and completed the graduate program in 4 years. His doctoral thesis investigated the role of the NF-kB/IkB family of transcription factors and he identified and cloned the IkBe gene. Next, he completed a 2-year postdoctoral fellowship at Harvard Medical School and the Brigham and Women’s Hospital. He was subsequently appointed to the faculty of the Harvard Medical School, where he continued his work on the regulation of gene expression in cancer, HIV and atherosclerosis. He has written numerous articles in leading peer-reviewed biomedical journals, has successfully competed for funding from private and government agencies and has held teaching appointments at Northeastern Illinois, Columbia and Boston College. At Wharton, he is a member of the Health Care and Biotechnology clubs, the Wharton Soccer team, and participates in the GUIDE mentoring program and is a member of the Volunteer Admissions Committee.